Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 1, 2026, Telefônica Brasil S.A. (VIV) has a Wall Street consensus price target of $13.25, based on estimates from 11 covering analysts. With the stock currently trading at $16.91, this represents a potential downside of -21.6%. The company has a market capitalization of $27.02B.
Analyst price targets range from a low of $12.00 to a high of $14.50, representing a 19% spread in expectations. The median target of $13.25 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 5 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 2 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, VIV trades at a trailing P/E of 25.8x and forward P/E of 3.0x. The forward PEG ratio of 1.11 indicates reasonable valuation for growth. Analysts expect EPS to grow +46.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $121.16, with bear and bull scenarios of $82.37 and $184.20 respectively. Model confidence stands at 47/100, suggesting limited visibility into future performance.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how VIV stacks up against sector leader Netflix, Inc..
Start ComparisonVIV's consensus price target is $13.25, -21.6% below the current price of $16.91. The 11 analysts tracking VIV see downside risk at present valuations.
VIV has a consensus rating of "Buy" based on 11 Wall Street analysts. The rating breakdown is mixed, with 4 Hold ratings making up the largest segment. The consensus 12-month price target of $13.25 implies -21.6% downside from current levels.
With a forward P/E of 2.9853x, VIV trades at a relatively low valuation. The consensus target of $13.25 implies -21.6% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $14.5 for VIV, while the most conservative target is $12. The consensus of $13.25 represents the median expectation. Our quantitative valuation model projects a bull case target of $184 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
VIV is moderately covered, with 11 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 4 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month VIV stock forecast based on 11 Wall Street analysts shows a consensus price target of $13.25, with estimates ranging from $12 (bear case) to $14.5 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $121, with bear/bull scenarios of $82/$184.
Our quantitative valuation model calculates VIV's fair value at $121 (base case), with a bear case of $82 and bull case of $184. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 47/100.
VIV trades at a forward P/E ratio of 3.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 25.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on VIV, with 2 Sell ratings and a price target of $13.25 (-21.6% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
VIV analyst price targets range from $12 to $14.5, a 19% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $13.25 consensus represents the middle ground. Our model's $82-$184 range provides an independent fundamental perspective.